Company Filing History:
Years Active: 2020-2023
Title: The Innovations of Peter McInerney
Introduction
Peter McInerney is a notable inventor based in La Jolla, California. He has made significant contributions to the field of nucleic acid amplification, holding 2 patents that showcase his innovative methods. His work has implications for various applications in biotechnology and molecular biology.
Latest Patents
One of Peter McInerney's latest patents is focused on the kinetic exclusion amplification of nucleic acid libraries. This method involves reacting a first solution containing target nucleic acids and a reagent mixture on a flow cell. The first solution is flowed over amplification sites, allowing the target nucleic acids to bind at a specific transport rate. The reagent mixture amplifies these bound nucleic acids, producing clonal populations of amplicons. The amplification occurs at a rate that exceeds the transport rate, ensuring efficient production of amplicons. A second solution, which lacks target nucleic acids, is then introduced to increase the number of amplicons at the amplification sites.
Career Highlights
Throughout his career, Peter McInerney has worked with prominent companies in the biotechnology sector, including Illumina Corporation and Illumina Cambridge Limited. His experience in these organizations has allowed him to refine his skills and contribute to groundbreaking advancements in nucleic acid technologies.
Collaborations
Peter has collaborated with notable colleagues such as Shaun Hunter and Jonathan Mark Boutell. These partnerships have fostered an environment of innovation and have led to the development of advanced methodologies in his field.
Conclusion
Peter McInerney's contributions to the field of nucleic acid amplification highlight his role as a leading inventor in biotechnology. His innovative patents and collaborations continue to influence advancements in molecular biology.